Comparison of methotrexate polyglutamylation in l1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor: Lack of evidence for influx route-specific effects

This publication has 34 references indexed in Scilit:

• Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line
  Published by Elsevier ,1995
• Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
  Journal of Clinical Oncology, 1995
• Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia
  Blood, 1995
• Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.
  Journal of Clinical Investigation, 1994
• Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia
  Blood, 1994
• Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia
  Blood, 1992
• Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma.
  Journal of Clinical Oncology, 1984
• Gene amplification in a leukemic patient treated with methotrexate.
  Journal of Clinical Oncology, 1984
• Resistance to methotrexate due to gene amplification in a patient with acute leukemia.
  Journal of Clinical Oncology, 1984
• A model system for the study of heteroexchange diffusion: Methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1971